705 related articles for article (PubMed ID: 28295220)
1. Total neoadjuvant therapy for rectal cancer: An emerging option.
Ludmir EB; Palta M; Willett CG; Czito BG
Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
[TBL] [Abstract][Full Text] [Related]
2. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
4. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer.
Smith CA; Kachnic LA
J Natl Compr Canc Netw; 2018 Jul; 16(7):909-915. PubMed ID: 30006431
[TBL] [Abstract][Full Text] [Related]
5. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
[TBL] [Abstract][Full Text] [Related]
6. Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management.
Franke AJ; Parekh H; Starr JS; Tan SA; Iqbal A; George TJ
Clin Colorectal Cancer; 2018 Mar; 17(1):1-12. PubMed ID: 28803718
[TBL] [Abstract][Full Text] [Related]
7. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
[TBL] [Abstract][Full Text] [Related]
8. A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers.
Langheinrich M; Paasch C; Mantke R; Weber K; Benz S; Kersting S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12591-12596. PubMed ID: 37438538
[TBL] [Abstract][Full Text] [Related]
9. Total neoadjuvant therapy for rectal cancer.
Goodman KA
Cancer Radiother; 2018 Sep; 22(5):459-465. PubMed ID: 29807808
[TBL] [Abstract][Full Text] [Related]
10. Advances in organ preserving strategies in rectal cancer patients.
Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
[TBL] [Abstract][Full Text] [Related]
11. Influence of neoadjuvant treatment strategy on perioperative outcomes in locally advanced rectal cancer.
McFeetors C; O'Connell LV; Choy M; Dundon N; Regan M; Joyce M; Meshkat B; Hogan A; Nugent E
Colorectal Dis; 2024 Apr; 26(4):684-691. PubMed ID: 38424706
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
[TBL] [Abstract][Full Text] [Related]
13. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer.
Gollins S; Sebag-Montefiore D
Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):146-151. PubMed ID: 26645661
[TBL] [Abstract][Full Text] [Related]
15. Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer.
Kang MK
World J Gastroenterol; 2023 Feb; 29(6):1011-1025. PubMed ID: 36844136
[TBL] [Abstract][Full Text] [Related]
16. Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer.
Conces ML; Mahipal A
Curr Oncol; 2024 Jan; 31(1):366-382. PubMed ID: 38248109
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant treatment for rectal cancer].
Bachet JB; Benoist S; Mas L; Huguet F
Bull Cancer; 2021 Sep; 108(9):855-867. PubMed ID: 34140155
[TBL] [Abstract][Full Text] [Related]
18. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
[TBL] [Abstract][Full Text] [Related]
19. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
20. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
